Nanomedicine and Life Sciences Companies

AION has focused on development of early stage diagnostics based on its nano-scale platform; modified porous silicon (mpSi).

A nano-biotechnology company with a nanoscale drug discovery technique for systematically scanning 'molecular diversity space'. The company has also developed technology for molecular manufacturing.

Ambri's technology is a novel biosensor technology based upon a synthetic self assembling membrane. The membrane acts like a biological switch and is capable of detecting the presence of specific molecules, and signalling their presence by triggering an electrical current.

Commercializes a nano and micron sized ceramic spheres technology that provides encapsulation and controlled release of active molecules for a variety of applications including drug delivery, cosmeceuticals and speciality chemicals.

EnGeneIC aims to revolutionize the treatment of cancer by targeted delivery of drugs or siRNAs using the same versatile nano-sized delivery vehicle to address the complexities found in cancer cells.

Living Cell is developing cell-based products to treat life threatening human diseases. The company has developed proprietary nanobiocapsules which allow encapsulated pig insulin producing cells, DiabeCell, to be implanted without the use of toxic immune suppressive drugs.

A nanobiotechnology company developing commercializing drug delivery products and new nanostructured biomaterials.

Quintain NanoSystems (Quintain NS) is the vehicle established in 2007 from the bionanotechnology activities of Nanotechnology Victoria Ltd. It's focus is towards development and commercialisation of diagnostic reagents and devices for human and animal health industries.

Develops dendrimer nanotechnology products for pharmaceutical, life-science and other applications.

Starpharma Holdings Limited is a world leader in the development of dendrimer nanotechnology products for pharmaceutical, life-science and other applications.